Found 5 results
Author Title [ Type
] Year Filters: Author is Rerks-Ngarm, Supachai [Clear All Filters]
. 2015. “Accuracy Of Clinical Diagnosis Of Dengue Episodes In The Rv144 Hiv Vaccine Efficacy Trial In Thailand.”. Plos One 10 (5). Plos One: e0127998. doi:10.1371/journal.pone.0127998.
. 2012. “Risk Behaviour And Time As Covariates For Efficacy Of The Hiv Vaccine Regimen Alvac-Hiv (Vcp1521) And Aidsvax B/e: A Post-Hoc Analysis Of The Thai Phase 3 Efficacy Trial Rv 144.”. Lancet Infect Dis 12 (7). Lancet Infect Dis: 531-7. doi:10.1016/S1473-3099(12)70088-9.
. 2011. “Safety And Reactogenicity Of Canarypox Alvac-Hiv (Vcp1521) And Hiv-1 Gp120 Aidsvax B/e Vaccination In An Efficacy Trial In Thailand.”. Plos One 6 (12). Plos One: e27837. doi:10.1371/journal.pone.0027837.
. 2012. “The Thai Phase Iii Trial (Rv144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes Within The V2 Region Of Hiv-1 Envelope.”. J Immunol 188 (10). J Immunol: 5166-76. doi:10.4049/jimmunol.1102756.
. 2009. “Vaccination With Alvac And Aidsvax To Prevent Hiv-1 Infection In Thailand.”. N Engl J Med 361 (23). N Engl J Med: 2209-20. doi:10.1056/NEJMoa0908492.